Rankings
▼
Calendar
IRD Q1 2020 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena
IRD
Opus Genetics, Inc.
$346M
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$3M
EPS (Diluted)
$-0.44
Cash Flow
Operating Cash Flow
-$732,000
Free Cash Flow
-$732,000
Stock-Based Comp.
$61,000
← FY 2020
All Quarters
Q2 2020 →